Bank of New York Mellon »

First Tracks Biotherapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.4M 70k 20.12

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Micron Technology (MU)
Meta Platforms Inc-class A Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding First Tracks Biotherapeutics

Sanofi
Financial Enhancement
Bank of New York Mellon
Moody Aldrich Partners
Fisher Investments
Tema Etfs
Russell Investments
Victory Capital Management
New York State Common Retirement Fund
China Universal Asset Management
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
GAMMA Investing
Sterling Capital Management
EverSource Wealth Advisors
Rothschild Investment

View all funds holding First Tracks Biotherapeutics